WooGene B&G Co., Ltd (KOSDAQ:018620)
2,765.00
-30.00 (-1.07%)
At close: Nov 13, 2026
WooGene B&G Market Cap
WooGene B&G has a market cap or net worth of 19.17 billion as of November 13, 2026. It is the 38,965th most valuable company in the world and the 2,419th biggest in South Korea. Its market cap has decreased by 24.68% in one year.
Market Cap
19.17B
Enterprise Value
68.54B
Revenue
56.49B
Global Rank
Country Rank
#2,419 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 20, 2008, WooGene B&G's market cap has increased from 18.33B to 19.17B, an increase of 4.60%. That is a compound annual growth rate of 0.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 19.17B | -20.15% |
| Dec 30, 2025 | 24.01B | -6.10% |
| Dec 30, 2024 | 25.57B | -27.76% |
| Dec 28, 2023 | 35.39B | -20.45% |
| Dec 29, 2022 | 44.49B | -26.67% |
| Dec 30, 2021 | 60.66B | -23.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyung Nam Pharm | 30.02B |
| HLscience | 29.95B |
| Korea Arlico Pharm | 29.12B |
| Pharmsville | 25.89B |
| Baskhanbio Pharma | 24.49B |
| Seoul Pharma | 20.40B |
| Daesung Microbiological Labs. | 20.14B |
| Union Korea Pharm | 19.70B |